 Abbott - the global health care company - was named to the Dow Jones Sustainability World Index and the Dow Jones Sustainability North America Index for the third consecutive year. This selection recognizes Abbott's continued leadership in business, environmental and social performance.
"Sustainability is a critical part of our approach to business," said Miles D. White, chairman and chief executive officer, Abbott. "Operating in a way that creates long-term value for our investors and stakeholders is an expectation of leaders across Abbott, from research and development, to marketing and sales, to human resources and environmental management. We're pleased to be recognized once again as a leader in our industry."
The Dow Jones Sustainability Indexes (DJSI) provide a benchmark of sustainability leadership around the globe. DJSI employs a "best-in-class" approach and analyzes corporate economic, environmental and social performance. This rigorous assessment covers issues such as corporate governance, risk management, access to medicines, climate change, supply chain standards, stakeholder engagement and labor practices.
As a member of the Dow Jones Sustainability World Index, Abbott is among the top 10 percent of the 2,500 largest companies worldwide in terms of sustainability. To learn more about Abbott's sustainability initiatives and to read or download the company's 2006 global citizenship report, please visit www.abbott.com/citizenship.
About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries. |
Explore the first worldwide Web 2.0 pharmaceutical news portal and 'Vote', 'Comment' or 'Submit' pharmaceutical news articles or other pharmaceutical web resources!
news
European Commission - Pharmaceuticals
US Food and Drug Administration 
